BUZZ1 Flashcards
Most potent risk factor
for osteoarthritis
Age
Initial analgesic of
choice for osteoarthritis
Acetaminophen/Paracetamol
Maximum dose of
acetaminophen in
osteoarthritis
1 gram TID
Earliest involved joints
in rheumatoid arthritis
Small joints of the hands and
feet
Subluxation of the 1st
MCP joint with
hyperextension of the
1st IP joint
Z-line deformity
Nodular RA,
splenomegaly and
neutropenia
Felty’s syndrome
DMARDs in RA
Methotrexate (first-line)
Sulfasalazine
Hydroxychloroquine
Leflunomide
Onset of action of
DMARDs
6 to 12 weeks (delayed)
Most serious toxicities
associated with use of
hydroxychloroquine
Irreversible retinal damage
Cardiotoxicity
Blood dyscrasia
Triple therapy in RA
Methotrexate
Sulfasalazine
Hydroxychloroquine
Avoid in G6PD
deficiency
Sulfasalazine
Category X DMARDs
Methotrexate
Leflunomide
Monitoring of serum
creatinine, CBC and liver
function tests during
methotrexate therapy
2 to 3 months
Biological in RA by
inhibiting the costimulation
of T-cells by
blocking CD28-CD80/86
interactions
Abatacept
TB screening required
prior to initiation of the
following biologics
TNF-α inhibitors (infliximab, etanercept, adalimumab, golimumab)
Abatacept, Anakinra
IL-6 inhibitors (tocilizumab, sarilumab)
Hallmark features of
psoriatic arthritis
Dactylitis, enthesitis
Most common acute
rash in SLE
Malar rash
Most common chronic
dermatitis in SLE
Discoid rash
Autoantibody in
subacute cutaneous
lupus
Anti-Ro (SS-A)
Anti-arrhythmic causing
drug-induced lupus
Procainamide
Disopyramide
Propafenone
Anti-hypertensives
causing drug-induced
lupus
Hydralazine
Methyldopa
ACE inhibitors
Beta-blockers
Anti-biotics causing
drug-induced lupus
Isoniazid
Minocycline
Nitrofurantoin
Other drugs causing
drug-induced lupus
Propylthiouracil
Chlorpromazine
Lithium
Positively birefringent,
rhomboid-shaped
crystals in synovial fluid
Calcium pyrophosphate (CPPD)
Negatively birefringent,
needle-shaped crystals
in synovial fluid
Urate (Gout)
Treatment of Raynaud’s
phenomenon
- Nonpharmacologic: dress
warmly, avoid cold exposure,
avoid drugs that exacerbate
vasospasm - Pharmacologic: Amlodipine,
diltiazem, ARBs, alphablockers
and PDE5-inhibitors
Maximum dose of
metformin in patients
with normal renal
function
2550 mg per day
Contraindications to
metformin use
eGFR < 30
Lactic acidosis
Severe hepatic failure
Diabetes drugs that can
cause weight loss
Metformin
α-glucosidase inhibitors
GLP1 receptor agonists
SGLT2 inhibitors
Diabetes drugs that are
weight neutral
DPP4 inhibitors
Diabetes drugs that can
cause weight gain
Insulin
Sulfonylureas
Thiazolidinediones
Diabetes drugs that can
cause hypoglycemia
Insulin
Sulfonylureas
Vitamin deficiency
associated with
metformin use
Vitamin B12
FDA approved drugs for
the treatment of painful
diabetic neuropathy
Pregabalin
Duloxetine
Tapentadol
Insulin with the longest
duration of action
Insulin degludec
Long-acting insulin with
fatty acid side chain
Insulin determir
Diabetes drug
associated with C-cell
hyperplasia in rats
GLP1 receptor agonists
SGLT2 inhibitor
associated with risk of
lower limb amputation
Canagliflozin
DPP4 inhibitor associated
with heart failure
Saxagliptin
Most common cause of
Cushing syndrome
Exogenous steroids
Most common cause of
Cushing disease
ACTH secreting pituitary
adenoma
Treatment of choice for
Cushing disease
Transsphenoidal surgical
resection